- Clinical trials test new drugs in many places.
- Few trials reflect people in the United States.
- Black people are often underrepresented in trials.
- Hispanic people are often underrepresented too.
- Asian representation has increased over time.
- White participation has stayed mostly stable.
- Many trials run only in a few regions.
- Parts of Africa and Latin America are left out.
- Researchers say we need more diversity early.
- This change can affect how drugs work.
Difficult words
- clinical trial — A study to test a new medicine.Clinical trials
- underrepresented — Not having enough people from a group.
- representation — The presence or number of a group.
- diversity — Many different kinds of people in a group.
- region — A large area or part of a country.regions
- researcher — A person who studies and tests things.Researchers
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Related articles
Coartem Baby: first malaria medicine for newborns
Swissmedic approved Coartem Baby in July 2025, the first antimalarial made for newborns under five kilograms. The tablet aims to close a long treatment gap in malaria-endemic parts of Sub-Saharan Africa.
Time of day may affect glioblastoma chemotherapy
New research finds that daily cycles of the DNA repair enzyme MGMT change during the day and may alter how glioblastoma responds to temozolomide. Biopsy timing and chronotherapy testing are next steps.
Affordable twice-yearly HIV injection lenacapavir to reach 120 countries
Lenacapavir, a twice-yearly HIV prevention injection, will be licensed for 120 low- and middle-income countries at US$40 a year. Rollout is expected from 2027 with funding support, but some countries and price transparency remain concerns.
Study finds Abbott-Bioline malaria test gives many false negatives
A study on the Thailand–Myanmar border found the Abbott-Bioline rapid malaria test missed many infections. Researchers call it “not fit for purpose”; WHO and the manufacturer are reviewing the test and further studies are under way.
Wearable 10‑Minute Antibody Sensors from University of Pittsburgh
Researchers at the University of Pittsburgh made a wearable biosensor that detects antibodies in interstitial fluid in 10 minutes without a blood draw. The tiny carbon nanotube sensors are highly sensitive and the work appears in Analytical Chemistry.
Why African Men Should Get Tested for Prostate Cancer
Prostate cancer is a major health issue for African men. Early testing can help improve survival rates.